Skip to main content
Have a personal or library account? Click to login
Sex Differences in Cardiovascular Disease Risk Factor Prevalence, Morbidity, and Mortality in Colombia: Findings from the Prospective Urban Rural Epidemiology (PURE) Study Cover

Sex Differences in Cardiovascular Disease Risk Factor Prevalence, Morbidity, and Mortality in Colombia: Findings from the Prospective Urban Rural Epidemiology (PURE) Study

Open Access
|Jan 2024

References

  1. Lopez-Jaramillo P, Joseph P, Lopez-Lopez JP, Lanas F, Avezum A, Diaz R, et al. Risk factors, cardiovascular disease, and mortality in South America: a PURE substudy. Eur Heart J. 2022; 43(30): 284151. DOI: 10.1093/eurheartj/ehac113
  2. Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020; 395(10226): 795808. DOI: 10.1016/S0140-6736(19)32008-2
  3. Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017; 70(1): 125. DOI: 10.1016/j.jacc.2017.04.052
  4. Bots SH, Peters SAE, Woodward M. Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between 1980 and 2010. BMJ Glob Health. 2017; 2(2): e000298. DOI: 10.1136/bmjgh-2017-000298
  5. Millett ERC, Peters SAE, Woodward M. Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants. BMJ. 2018; 363: k4247. DOI: 10.1136/bmj.k4247
  6. de Jong M, Woodward M, Peters SAE. Diabetes, Glycated Hemoglobin, and the Risk of Myocardial Infarction in Women and Men: A Prospective Cohort Study of the UK Biobank. Diabetes Care. 2020; 43(9): 20509. DOI: 10.2337/dc19-2363
  7. Gauci S, Cartledge S, Redfern J, Gallagher R, Huxley R, Lee CMY, et al. Biology, Bias, or Both? The Contribution of Sex and Gender to the Disparity in Cardiovascular Outcomes Between Women and Men. Curr Atheroscler Rep. 2022; 24(9): 7018. DOI: 10.1007/s11883-022-01046-2
  8. Stehli J, Martin C, Brennan A, Dinh DT, Lefkovits J, Zaman S. Sex Differences Persist in Time to Presentation, Revascularization, and Mortality in Myocardial Infarction Treated With Percutaneous Coronary Intervention. J Am Heart Assoc. 2019; 8(10): e012161. DOI: 10.1161/JAHA.119.012161
  9. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003; 349(6): 52334. DOI: 10.1056/NEJMoa030808
  10. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002; 288(3): 32133. DOI: 10.1001/jama.288.3.321
  11. Cho L, Davis M, Elgendy I, Epps K, Lindley KJ, Mehta PK, et al. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020; 75(20): 260218. DOI: 10.1016/j.jacc.2020.03.060
  12. Del-Sueldo MA, Mendonca-Rivera MA, Sanchez-Zambrano MB, Zilberman J, Munera-Echeverri AG, Paniagua M, et al. Clinical practice guideline of the Interamerican Society of Cardiology on primary prevention of cardiovascular disease in women. Arch Cardiol Mex. 2022; 92(Supl 2): 168. DOI: 10.24875/ACM.22000071
  13. Benziger CP, Roth GA, Moran AE. The Global Burden of Disease Study and the Preventable Burden of NCD. Glob Heart. 2016; 11(4): 3937. DOI: 10.1016/j.gheart.2016.10.024
  14. Leening MJ, Ferket BS, Steyerberg EW, Kavousi M, Deckers JW, Nieboer D, et al. Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study. BMJ. 2014; 349: g5992. DOI: 10.1136/bmj.g5992
  15. van der Meer MG, Cramer MJ, van der Graaf Y, Doevendans PA, Nathoe HM. Gender difference in long-term prognosis among patients with cardiovascular disease. Eur J Prev Cardiol. 2014; 21(1): 819. DOI: 10.1177/2047487312460519
  16. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020; 76(25): 29823021. DOI: 10.1016/j.jacc.2020.11.010
  17. Walli-Attaei M, Joseph P, Rosengren A, Chow CK, Rangarajan S, Lear SA, et al. Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020; 396(10244): 97109. DOI: 10.1016/S0140-6736(20)30543-2
  18. Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S, Group PI-W. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J. 2009; 158(1): 17 e1. DOI: 10.1016/j.ahj.2009.04.019
  19. McCullough ML, Feskanich D, Stampfer MJ, Giovannucci EL, Rimm EB, Hu FB, et al. Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr. 2002; 76(6): 126171. DOI: 10.1093/ajcn/76.6.1261
  20. Schatzkin A, Cupples LA, Heeren T, Morelock S, Kannel WB. Sudden death in the Framingham Heart Study. Differences in incidence and risk factors by sex and coronary disease status. Am J Epidemiol. 1984; 120(6): 88899. DOI: 10.1093/oxfordjournals.aje.a113960
  21. Pinho-Gomes AC, Peters SAE, Thomson B, Woodward M. Sex differences in prevalence, treatment and control of cardiovascular risk factors in England. Heart. 2020 Sep 4; heartjnl-2020-317446. DOI: 10.1136/heartjnl-2020-317446
  22. Arora S, Stouffer GA, Kucharska-Newton AM, Qamar A, Vaduganathan M, Pandey A, et al. Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction. Circulation. 2019; 139(8): 104756. DOI: 10.1161/CIRCULATIONAHA.118.037137
  23. Khan E, Brieger D, Amerena J, Atherton JJ, Chew DP, Farshid A, et al. Differences in management and outcomes for men and women with ST-elevation myocardial infarction. Med J Aust. 2018; 209(3): 11823. DOI: 10.5694/mja17.01109
  24. Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J. 2008; 29(7): 93240. DOI: 10.1093/eurheartj/ehn018
  25. Dev R, Favour-Ofili D, Raparelli V, Behlouli H, Azizi Z, Kublickiene K, et al. Sex and Gender Influence on Cardiovascular Health in Sub-Saharan Africa: Findings from Ghana, Gambia, Mali, Guinea, and Botswana. Glob Heart. 2022; 17(1): 63. DOI: 10.5334/gh.1146
  26. Walli-Attaei M, Rosengren A, Rangarajan S, Breet Y, Abdul-Razak S, Sharief WA, et al. Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study. Lancet. 2022; 400(10355): 81121. DOI: 10.1016/S0140-6736(22)01441-6
  27. Cholesterol Treatment Trialists C, Fulcher J, O’Connell R, Voysey M, Emberson J, Blackwell L, et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015; 385(9976): 1397405. DOI: 10.1016/S0140-6736(14)61368-4
  28. Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. 2009; 54(25): 236673. DOI: 10.1016/j.jacc.2009.10.009
  29. Thurston RC, Karvonen-Gutierrez CA, Derby CA, El Khoudary SR, Kravitz HM, Manson JE. Menopause versus chronologic aging: their roles in women’s health. Menopause. 2018; 25(8): 84954. DOI: 10.1097/GME.0000000000001143
  30. Lopez-Lopez JP, Cohen DD, Alarcon-Ariza N, Mogollon-Zehr M, Ney-Salazar D, Chacon-Manosalva MA, et al. Ethnic Differences in the Prevalence of Hypertension in Colombia: Association With Education Level. Am J Hypertens. 2022; 35(7): 6108. DOI: 10.1093/ajh/hpac051
  31. Bukkapatnam RN, Gabler NB, Lewis WR. Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis. Prev Cardiol. 2010; 13(2): 8490. DOI: 10.1111/j.1751-7141.2009.00059.x
DOI: https://doi.org/10.5334/gh.1289 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jun 8, 2023
Accepted on: Dec 21, 2023
Published on: Jan 24, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Jose Patricio Lopez-Lopez, Martin Rebolledo-Del Toro, Daniel Martinez-Bello, Ángel A. Garcia-Peña, Gary O’Donovan, Maritza Perez-Mayorga, Johanna Otero, Sumathy Rangarajan, Salim Yusuf, Patricio Lopez-Jaramillo, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.